$EXAS:NASDAQ · Exact Sciences Corporation
Conviction from: NASDAQCitrini
Exact Sciences — Cologuard cancer screening. (acquired by Abbott / ABT, 2026)
Not currently held by tracked 13F filers — this page aggregates activist, insider, politician and research activity.
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-03-24 | Kevin Hern OK01 | SELL | $1,001 - $15,000 | PTR |
1 disclosed trade(s) by 1 filer(s).
| Report | Date | Stance |
|---|
| #84 — Market Memo: Healthcare's AI-Powered Trump Card | 2025-02-09 | LONG |
| #80 — Market Memo: January Musings | 2025-01-09 | LONG |